Congress should embrace new medical methods and technologies, like gene therapy treatments, because they may become cheaper than traditional medicines over time, Rep. Scott Peters (D-Calif.) said during an Axios virtual event on Monday.

What he's saying: "People, their initial reaction to technologies is that it must be more expensive," Peters said. "It's our job to show that it's more cost-effective over time."